Clarivate Analytics has announced its collaboration with the University of Melbourne, which is leading the ARC Training Centre for Personalized Therapeutics Technologies, a collaboration between University of Melbourne, Monash University, University of Western Australia and 15 partner organizations including Clarivate.
Funded by the Australian Research Council's (ARC) Industrial Transformation Training Centres schemes over five years, the Centre is led by Professor Alastair Stewart from the Department of Pharmacology and Therapeutics, University of Melbourne. The Centre aims to create and develop in Australia the skills and technology to generate early benefits from the transformative impacts that cell/organ-on-a chip technology will have on the medical technology and pharmaceutical industries, as well as deliver on the potential of the era of personalised medicine. Guiding therapeutic use by personalised bioassays promises to enable disease to be modelled or diagnosed with increased precision.
As industry partner of the Centre, Clarivate Analytics will provide significant in-kind support by having its senior life sciences solutions expert conduct an annual master class over five years for researchers on topics covering how to identify competitors, achieve clinical milestones, map the intellectual property (IP) landscape of similar clinical targets and assess the value of drug discovery. To help master class students gain practical know-how, Clarivate will also provide free access to its flagship pharma intelligence software, Cortellis Competitive Intelligence, for a limited period.
Currently, Clarivate conducts commercialisation, partnering and regulatory intelligence lectures which form the curriculum in the Masters of Biotechnology Undergraduate program offered by the University of Melbourne.
Brought to you by Scope e-Knowledge Center, a world-leading provider of Abstracting & Indexing (A&I) Services, Knowledge Modeling Services (Taxonomies, Thesauri and Ontologies), Metadata Enrichment & Entity Extraction Services.
